NNOX
Get informed when a big investor buys or sells
+ FollowOvervalued by 635.9% based on the discounted cash flow analysis.
| Market cap | $69.44 Million |
|---|---|
| Enterprise Value | $33.22 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 1.27 |
| Outstanding Shares | 69,619,000 |
| P/E Ratio | -0.88 |
|---|---|
| PEG | -11.29 |
| Price to Sales | - |
| Price to Book Ratio | 0.99 |
| Enterprise Value to Revenue | 2.29 |
| Enterprise Value to EBIT | -0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.06 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.1121▲ 271.50% |
|---|---|
| Total Calls | 10,700▼ 98.44% |
| Total Puts | 33,300▼ 87.76% |
Holdings and activity of institutional investors.
| Ownership % | 2.15%▼ 23.57% |
|---|---|
| Total Invested | $1.74M▼ 95.73% |
| Investors Holding | 40▼ 93.00% |
No data
Nano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.